Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid Closes $345M Offering of Convertible Senior Notes

NEW YORK (GenomeWeb News) – Cepheid said after the close of the market on Monday that it has closed its $345 million offering of 1.25 percent convertible senior notes.

The offering includes $300 million of notes that were sold to qualified institutional investors and $45 million of notes that were issued pursuant to the exercise of an overallotment option by the notes' initial purchasers, Morgan Stanley and Jefferies. The notes are due in 2021.

Cepheid initially said it would offer $250 million of convertible senior notes, but later increased the amount to $300 million.

Cepheid said that net proceeds from the offering are estimated to be $336.4 million. About $25.1 million was used to pay the cost of a type of security called capped call transactions that the company entered into in connection with the offering. The remainder of the proceeds will go toward general corporate purposes, including potential acquisitions and strategic transactions.

Filed under

The Scan

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.

Topical Compound to Block EGFR Inhibitors May Ease Skin Toxicities, Study Finds

A topical treatment described in Science Translational Medicine may limit skin toxicities seen with EGFR inhibitor therapy.

Dozen Genetic Loci Linked to Preeclampsia Risk in New GWAS

An analysis of genome-wide association study data in JAMA Cardiology finds genetic loci linked to preeclampsia that have ties to blood pressure.

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.